Drug
Niraparib Combined With Mgd013
Niraparib Combined With Mgd013: highest development phase Phase 1, developed by Zai Lab. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Zai Lab
Trials
| Drug | Phase | Indication |
|---|---|---|
| Niraparib combined with MGD013 NCT04178460 | Phase 1 | Gastric Cancer |
Latest
No recent events.
Follow Niraparib Combined With Mgd013 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.